4.3 Article

Artificial intelligence-assisted cancer diagnosis improves the efficiency of pathologists in prostatic biopsies

期刊

VIRCHOWS ARCHIV
卷 482, 期 3, 页码 595-604

出版社

SPRINGER
DOI: 10.1007/s00428-023-03518-5

关键词

Artificial intelligence; Prostate cancer; Computational pathology; Digital pathology

向作者/读者索取更多资源

Paige Prostate is a clinical-grade AI tool that assists pathologists in detecting and grading prostate cancer. In a study with 105 prostate core needle biopsies, pathologists using Paige Prostate showed improved diagnostic accuracy and efficiency compared to those without assistance. The use of Paige Prostate reduced the need for additional tests and second opinions, and decreased the time required for reading and reporting slides.
Paige Prostate is a clinical-grade artificial intelligence tool designed to assist the pathologist in detecting, grading, and quantifying prostate cancer. In this work, a cohort of 105 prostate core needle biopsies (CNBs) was evaluated through digital pathology. Then, we compared the diagnostic performance of four pathologists diagnosing prostatic CNB unaided and, in a second phase, assisted by Paige Prostate. In phase 1, pathologists had a diagnostic accuracy for prostate cancer of 95.00%, maintaining their performance in phase 2 (93.81%), with an intraobserver concordance rate between phases of 98.81%. In phase 2, pathologists reported atypical small acinar proliferation (ASAP) less often (about 30% less). Additionally, they requested significantly fewer immunohistochemistry (IHC) studies (about 20% less) and second opinions (about 40% less). The median time required for reading and reporting each slide was about 20% lower in phase 2, in both negative and cancer cases. Lastly, the average total agreement with the software performance was observed in about 70% of the cases, being significantly higher in negative cases (about 90%) than in cancer cases (about 30%). Most of the diagnostic discordances occurred in distinguishing negative cases with ASAP from small foci of well-differentiated (less than 1.5 mm) acinar adenocarcinoma. In conclusion, the synergic usage of Paige Prostate contributes to a significant decrease in IHC studies, second opinion requests, and time for reporting while maintaining highly accurate diagnostic standards.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据